Dallah Healthcare Company (TADAWUL:4004)

Market Cap	10.76B -8.8%
Revenue (ttm)	4.25B +30.5%
Net Income	467.23M -7.9%
EPS	4.58 -12.0%
Shares Out	100.97M
PE Ratio	23.28
Forward PE	21.94
Dividend	2.00 (1.88%)
Ex-Dividend Date	May 18, 2026

Volume	86,204
Open	108.30
Previous Close	108.40
Day's Range	106.00 - 108.30
52-Week Range	90.00 - 157.30
Beta	-0.45
Analysts	Hold
Price Target	130.74 (+22.65%)
Earnings Date	Aug 10, 2026

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It also offers pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, as well as medications, diagnostics, and medical technologies. In addition, the company provides personalized treatment plans, post-surgical recovery and chronic ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1987
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4004

Financial Performance

In 2025, Dallah Healthcare Company's revenue was 4.07 billion, an increase of 26.86% compared to the previous year's 3.21 billion. Earnings were 538.27 million, an increase of 14.23%.

Analyst Summary

According to 8 analysts, the average rating for 4004 stock is "Hold." The 12-month stock price target is SAR 130.74, which is an increase of 22.65% from the latest price.

Price Target

SAR 130.74

(22.65% upside)

Analyst Consensus: Hold